Developing the 2013 WHO consolidated antiretroviral guidelines

AIDS

Volumn 28, Issue SUPPL. 2, 2014, Pages

  Easterbrook, Philippa J ^a   Irvine, Cadi J ^a   Vitoria, Marco ^a   Shaffer, Nathan ^a   Muhe, Lulu M ^a   Negussie, Eyerusalem K ^a   Doherty, Meg C ^a   Ball, Andrew ^a   Hirnschall, Gottfried ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DISABILITY ADJUSTED LIFE YEAR; EVIDENCE BASED MEDICINE; GROUPS BY AGE; HEALTH CARE DELIVERY; HEALTH CARE SURVEY; HEPATITIS B; HEPATITIS C; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; MATHEMATICAL MODEL; MIDDLE INCOME GROUP; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIOECONOMICS; SYSTEMATIC REVIEW (TOPIC); TREATMENT RESPONSE; TUBERCULOSIS; VIRUS LOAD; WORLD HEALTH ORGANIZATION; HIV INFECTIONS; LITERATURE; META ANALYSIS (TOPIC);

ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HUMANS; META-ANALYSIS AS TOPIC; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 84901438250     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000253     Document Type: Article

References (42)

1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013, www.who.int/hiv/pub/guidelines/arv2013. [Accessed 26 January 2014]
2. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach [2010 revision]. Geneva: World Health Organization; 2010, http://whqlibdoc.who.int/ publications/2010/9789241599764-eng.pdf. [Accessed 26 January 2014]
3. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach [2010 revision]. Geneva: World Health Organization; 2010, http://whqlibdoc.who.int/publications/2010/ 9789241599818-eng.pdf. [Accessed 26 January 2014]
4. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach [2010 revision]. Geneva: World Health Organization; 2010, http://whqlibdoc. who.int/publications/2010/9789241599801-eng.pdf. [Accessed 26 January 2014]
5. Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A. The next generation of the World Health Organization's global antiretroviral guidance. J Int AIDS Soc 2013; 16:18757.
6. Anglemyer A, Rutherford GW, Easterbrook PJ, Horvath T, Vitó ria M, Jan M, Doherty MC. Early initiation of antiretroviral therapy in HIV-infected adults and adolescents: a systematic review. AIDS 2014; 28 (Supp 2):S105-S118.
7. Ford N, Mofenson L, Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, et al. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS 2014; 28 (Suppl 2):S123-S131.
8. Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams EJ. Optimization of antiretroviral therapy in HIVinfected children under 3 years of age: a systematic review. AIDS 2014; 28 (Supp 2):S137-S146.
9. Tucker JD, Bien CH, Easterbrook PJ, Doherty MC, Prenazzato M, Vitoria M, Peeling RW. Optimal strategies for monitoring response to antiretroviral therapy in HIV-infected adults, adolescents, children and pregnant women: a systematic review. AIDS 2014; 28 (Suppl 2):S151-S160.
10. Rutherford GW, Anglemyer A, Easterbrook PJ, Horvath T, Vitoria M, Penazzato M, Doherty MC. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. AIDS 2014; 28 (Suppl 2):S161-S169.
11. Suthar AB, Rutherford GW, Horvath T, Doherty MC, Negussie EK. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization. AIDS 2014; 28 (Suppl 2):S175-S185.
12. Chaiyachati KH, Ogbuoji O, Price M, Suthar AB, Negussie EK, Bärnignausen T. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS 2014; 28 (Supp 2):S187-S204.
13. Eholie SP, Vella S, Anglaret X. Commentary: Antiretroviral therapy initiation criteria in low resource settings-from 'when to start' to 'when not to start'. AIDS 2014; 28:S101-S104.
14. Tsague L, Abrams EJ. Commentary: Antiretroviral treatment for pregnant and breastfeeding women-the shifting paradigm. AIDS 2014; 28 (Supp 2):S119-S121.
15. Siberry G, Tindyebwa D. Commentary: When to start and what to use in children-recommendations and rationale. AIDS 2014; 28 (Supp 2):S133-S135.
16. Essajee S, Kumarasamy N. Commentary: The monitoring of adults and children on antiretroviral therapy in the 2013WHO consolidated ARV guidelines. AIDS 2014; 28 (Supp 2):S147-S149.
17. Assefa Y, Pillay Y, Van Damme W. Commentary: Operational Guidance in the 2013 WHO consolidated antiretroviral guidelines. AIDS 2014; 28 (Supp 2):S171-S173.
18. Hsieh AC, Mburu G, Garner ABJ, Teltschik A, Ram M, Mallouris C, et al. Community and service provider views to inform the 2013WHOconsolidated antiretroviral guidelines: key findings and lessons learnt. AIDS 2014; 28 (Supp 2):S205-S216.
19. Nelson LJ, Beusenberg M, Habiyambere V, Shaffer N, Vitoria MA, Gonzalez Montero R, et al. Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines. AIDS 2014; 28 (Supp 2): S217-S224.
20. Stover J, Gopalappa C, Mahy M, Doherty MC, Easterbrook PJ, Weiler G, Ghys PD. The impact and cost of the WHO 2013 recommendations on eligibility for antiretroviral therapy. AIDS 2014; 28 (Supp 2):S225-S230.
21. Holmes C, Pillay Y, Mwango A, Perriens J, Ball A, Barrenche O, et al. Health systems implications of the 2013 WHO consolidated antiretroviral guidelines and strategies for successful implementation. AIDS 2014; 28 (Supp 2):S231-S239.
22. Kredo T, Ford N, Adeniyi FB, Garner P. Decentralising HIV treatment in lower-and middle-income countries. Cochrane Database Syst Rev 2013; 6:CD009987.
23. Suthar AB, Hoos D, Beqiri A, Lorenz-Dehne K, McClure C, Duncombe C. Integrating antiretroviral therapy into antenatal care and maternal and child health settings: a systematic review and meta-analysis. Bull World Health Organ 2013; 91:46-56.
24. Suthar AB, Ford N, Bachanas PJ, Wong VJ, Rajan JS, Saltzman AK, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of communitybased approaches. PLoS Med 2013; 10:e1001496.
25. Siegfried N, Davies MA, Penazzato M, Muhe LM, Egger M. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old. Cochrane Database Syst Rev 2013; 10:CD010309.
26. Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health 2014; 2:e23-e34.
27. Keebler D, Revill P, Braithwaite S, Phillips A, Blaser N, Borquez A, et al. Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models. Lancet Glob Health 2014; 2:e35-e43.
28. Schomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technauk I, et al. International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA) Collaboration. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modeling analysis of cohort studies from southern Africa. PLoS Med 2013; 10:e1001555.
29. Hallett TB, Menzies NA, Revill P, Keebler D, Borquez A, McRobie E, et al. Using modeling to inform international guidelines for antiretroviral treatment. AIDS 2014; 28 (Suppl 1):S1-S4.
30. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-510.
31. World Health Organization. WHO handbook for guideline development. Geneva: World Health Organization; 2012.
32. Guyatt GH, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64:383-394.
33. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Visit G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64:395-400.
34. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64:401-406.
35. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 2011; 64:407-415.
36. Guyatt GD, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8: rating the quality of evidence-indirectness. J Clin Epidemiol 2011; 64:1303-1310.
37. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Ekl EA, Alonso-Coello P, et al. The GRADE Working Group GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 2011; 64:1311-1316.
38. Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerphol JJ, Coello PA, et al. GRADE guidelines: 15 Going from evidence to recommendations-determinants of a recommendation's direction and strength. J Clin Epidemiol 2013; 66:726-735.
39. Community consultation to inform the 2013WHOconsolidated ARV guidelines International HIV/AIDS Alliance and Global Network of people Living with HIV September 2013. http://www.aidsalliance.org/includes/Publication/1.%20Community %20Consultation%20Report.pdf. [Accessed 26 January 2014]
40. Easterbrook PJ, Doherty M, Perriens J, et al. The role of mathematical modeling in the development of recommendations in the 2013 WHO consolidated antiretroviral therapy guidelines. AIDS Suppl 2014; 28 (Suppl 1):S28-S92.
41. Futures Institute. Goals manual: a model for estimating the effects of interventions and resource allocation on HIV infections and deaths. August 2011. http://www.futuresinstitute.org
42. Alexander PE, Bero L, Montori VM, Britog JP, Stoltzfnsh R, Djulbegovic B, et al. World Health Organization recommendations are often strong based on low confidence in effect estimates. J Clin Epidemiol 2014; pii:S0895-S4356.